Highlighting research presented by Pharmacists at the 2023 Neurocritical Care Society Annual Meeting

Nick celebrates the 100th episode of the podcast before switching gears and celebrating the 11 winners of the 10 award categories from the First Annual Pharmacy to Dose Awards.

Joseph Lam joins me to highlight his research team's study, Phenobarbital for acute alcohol withdrawal: a prospective, randomized, double-blind, placebo-controlled study published in the Journal of Emergency Medicine in 2013.

Lance Ray and Kyle DeWitt join me to give an overview on the management of arrhythmias in the Emergency Department, highlighting their 2-part review on this same topic published in AJHP

Dr. Ashish Khanna, principal investigator of the ATHOS-3 research team, joins me to highlight the landmark ATHOS-3 trial as the Trial of the Week.

Carolyn Bell joins me to discuss her first author research study, the Insidious Harm of Medication Diluents, published in August 2018 in Critical Care Medicine.

Casey May joins me to highlight 2 recent guideline statements on the management of aSAH patients. We review guideline recommendations, what's missing, pertinent pharmacotherapy, future research ideas, and much, much more.

Melissa Thompson Bastin joins me to discuss her review on oseltamivir dosing in the critically ill, published in 2014 in the Annals of Pharmacotherapy.

Dave Dixon joins me to highlight his experience on the heart failure with preserved ejection fraction (HFpEF) consensus decision pathway, before diving into all things HFpEF and its pharmacotherapy.

Steven Lemieux joins me to discuss ARDS, specifically highlighting the 2023 ESICM guidelines while also discussing severe ARDS pharmacotherapy

Scott Benken joins me to promote the C4 conference and review the landmark CATS trial, researching norepinephrine and dobutamine compared to epinephrine in septic shock

Aaron Cook and Alex Flannery join me for the inaugural Trial of the Week to discuss one of their most recognized publications

Erin McCreary and Jason Pogue join me to break down the MERCY trial, published in JAMA in July 2023, comparing continuous v intermittent administration of meropenem in sepsis

Kelly Oldziej, PharmD joins me to highlight the notable articles from May 2023.

Matt Wanat joins me in the first ever Pharmacy to Dose: Versus Series, where 2 critical care pharmacotherapy agents square off to determine a champion. Matt is defending amiodarone, and Nick is defending lidocaine.

COPD Discussion with Ty Kiser where we dive into the new 2023 GOLD Report, discuss pharmacotherapy in AECOPD, considerations for maintenance medications, future research, and much more.

Andy Webb joins me for Part II of BP Control in Neurologic Emergencies, focusing on antihypertensive pharmacotherapy and treatment considerations for the neurocritical care patient

Andy Webb joins me in Part I of Blood Pressure Control in Neurologic Emergencies, focusing on the individual emergencies themselves with specific BP goals, landmark trials, and other considerations.

Leslie Hamilton joins me to highlight 2 studies that were discussed at ESOC 2023, but haven't been published yet.

6 Pharmacists highlight their research presented at the 2023 SAEM Annual Meeting with Nick

Keaton Smetana and Todd Miano join Nick to dive into the INTERACT3 results, statistics, ultimate take-aways, and much more.

Nick reviews some of the most notable articles from April 2023

Part II in the series discussing perioperative emergencies and perioperative clinical pharmacy services

Official announcement of the Podcast Partnership as well as the 2023 Pharmacy to Dose Awards nomination information

Joined by 4 Perioperative Clinical Pharmacists to discuss a general overview into the roles/responsibilities before reviewing the management of cardiac arrests in the OR and sugammadex.